tiagabine has been researched along with Psychotic Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, JM; Janicak, PG; Martis, B; Omens, R; Sharma, RP | 1 |
1 trial(s) available for tiagabine and Psychotic Disorders
| Article | Year |
|---|---|
Tiagabine, a specific gamma-aminobutyric acid transporter-1 inhibitor, in the treatment of psychosis.
Topics: Adult; Carrier Proteins; Female; GABA Agonists; GABA Plasma Membrane Transport Proteins; Humans; Male; Membrane Proteins; Membrane Transport Proteins; Nipecotic Acids; Organic Anion Transporters; Psychotic Disorders; Tiagabine | 2001 |